Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.

[1]  P. Stattin,et al.  Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden , 2017, JAMA oncology.

[2]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[3]  David Gillatt,et al.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.

[4]  M. Roobol,et al.  A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment. , 2016, European urology.

[5]  J. Hugosson,et al.  Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial. , 2016, European urology.

[6]  R. Walters,et al.  Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database , 2016, Prostate Cancer and Prostatic Diseases.

[7]  Ronald C. Chen,et al.  Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Hartwig Huland,et al.  Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment? , 2015, European urology.

[9]  M. Cooperberg,et al.  Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. , 2015, JAMA.

[10]  N. Lawrentschuk,et al.  The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry , 2015, BJU international.

[11]  M. Menon,et al.  The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. , 2014, European urology.

[12]  Jennifer R. Rider,et al.  Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer , 2014 .

[13]  M. Cooperberg,et al.  Active surveillance for prostate cancer: a systematic review of the literature. , 2012, European urology.

[14]  L. Holmberg,et al.  Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. , 2012, European urology.

[15]  Angela Mariotto,et al.  Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. , 2009, Journal of the National Cancer Institute.

[16]  R. V. D. van den Bergh,et al.  Prospective validation of active surveillance in prostate cancer: the PRIAS study. , 2007, European urology.

[17]  T. H. van der Kwast,et al.  Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. , 2006, European urology.

[18]  Neil Fleshner,et al.  Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. , 2002, The Journal of urology.

[19]  Guy Vallancien,et al.  Robotically Assisted Laparoscopic Radical Prostatectomy: Feasibility Study in Men , 2001, European Urology.

[20]  A. D'Amico,et al.  A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.

[21]  David C. Miller,et al.  Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. , 2015, European urology.

[22]  Timothy J Wilt,et al.  Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.